MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma

Por Vella, Serena, Pomella, Silvia, Leoncini, Pier Paolo, Colletti, Marta, Conti, Beatrice, Marquez, Victor E., Strillacci, Antonio, Roma, Josep, Gallego, Soledad, Milano, Giuseppe M., Capogrossi, Maurizio C., Bertaina, Alice, Ciarapica, Roberta, Rota, Rossella
Publicado no Clin Epigenetics (2015)

Serum miR-29a is upregulated in acute Graft versus Host Disease and activates dendritic cells through TLR binding

Por Ranganathan, Parvathi, Ngankeu, Apollinaire, Zitzer, Nina C., Leoncini, PierPaolo, Yu, Xueyan, Casadei, Lucia, Challagundla, Kishore, Reichenbach, Dawn K., Garman, Sabrina, Ruppert, Amy S., Volinia, Stefano, Hofstetter, Jessica, Efebera, Yvonne A., Devine, StevenM., Blazar, Bruce R., Fabbri, Muller, Garzon, Ramiro
Publicado no J Immunol (2017)

MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment

Por Leoncini, Pier Paolo, Bertaina, Alice, Papaioannou, Dimitrios, Flotho, Christian, Masetti, Riccardo, Bresolin, Silvia, Menna, Giuseppe, Santoro, Nicola, Zecca, Marco, Basso, Giuseppe, Nigita, Giovanni, Veneziano, Dario, Pagotto, Sara, D'Ovidio, Katia, Rota, Rossella, Dorrance, Adrienne, Croce, Carlo M., Niemeyer, Charlotte, Locatelli, Franco, Garzon, Ramiro
Publicado no Oncotarget (2016)

Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS

Por Ciarapica, Roberta, Carcarino, Elena, Adesso, Laura, De Salvo, Maria, Bracaglia, Giorgia, Leoncini, Pier Paolo, Dall’Agnese, Alessandra, Verginelli, Federica, Milano, Giuseppe M, Boldrini, Renata, Inserra, Alessandro, Stifani, Stefano, Screpanti, Isabella, Marquez, Victor E, Valente, Sergio, Mai, Antonello, Puri, Pier Lorenzo, Locatelli, Franco, Palacios, Daniela, Rota, Rossella
Publicado em 2014